Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R C Rathbun

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Current Pharmaceutical Design|March 7, 2006
Current HIV treatment guidelines--an overviewR C Rathbun, S M Lockhart, J R Stephens
Pharmacotherapy|November 1, 1995
Hyperkalemia associated with high-dose trimethoprim-sulfamethoxazole in a patient with the acquired immunodeficiency syndromeL B Mihm, R C Rathbun, B H Resman-Targoff
Clinical Pharmacy|April 1, 1991
Current and investigational therapies for AIDS-associated Mycobacterium avium complex diseaseR C Rathbun, E S Martin, V E Eaton, et al.
Life Sciences|September 5, 1983
Enhanced binding of radioligands to receptors of gamma-aminobutyric acid and benzodiazepine by a new anticonvulsive agent, LY81067D T Wong, R C Rathbun, F P Bymaster, et al.
Epilepsia|November 1, 1988
Pharmacology of LY201409, a potent benzamide anticonvulsantD W Robertson, R R Lawson, R C Rathbun, et al.
Epilepsia|January 1, 1988
Pharmacological effects of enantiomers of 4-amino-N-(alpha-methylbenzyl)benzamide, a chemically novel anticonvulsantJ D Leander, D W Robertson, C R Clark, et al.
Journal of Medicinal Chemistry|September 1, 1986
Structure-activity relationships of (arylalkyl)imidazole anticonvulsants: comparison of the (fluorenylalkyl)imidazoles with nafimidone and denzimolD W Robertson, J H Krushinski, E E Beedle, et al.
HIV Medicine|April 3, 2016
HIV Pharmacist's Impact on Inpatient Antiretroviral ErrorsM D Liedtke, C R Tomlin, G H Skrepnek, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Current Pharmaceutical Design|March 7, 2006
Current HIV treatment guidelines--an overviewR C Rathbun, S M Lockhart, J R Stephens
Pharmacotherapy|November 1, 1995
Hyperkalemia associated with high-dose trimethoprim-sulfamethoxazole in a patient with the acquired immunodeficiency syndromeL B Mihm, R C Rathbun, B H Resman-Targoff
Clinical Pharmacy|April 1, 1991
Current and investigational therapies for AIDS-associated Mycobacterium avium complex diseaseR C Rathbun, E S Martin, V E Eaton, et al.
Life Sciences|September 5, 1983
Enhanced binding of radioligands to receptors of gamma-aminobutyric acid and benzodiazepine by a new anticonvulsive agent, LY81067D T Wong, R C Rathbun, F P Bymaster, et al.
Epilepsia|November 1, 1988
Pharmacology of LY201409, a potent benzamide anticonvulsantD W Robertson, R R Lawson, R C Rathbun, et al.
Epilepsia|January 1, 1988
Pharmacological effects of enantiomers of 4-amino-N-(alpha-methylbenzyl)benzamide, a chemically novel anticonvulsantJ D Leander, D W Robertson, C R Clark, et al.
Journal of Medicinal Chemistry|September 1, 1986
Structure-activity relationships of (arylalkyl)imidazole anticonvulsants: comparison of the (fluorenylalkyl)imidazoles with nafimidone and denzimolD W Robertson, J H Krushinski, E E Beedle, et al.
HIV Medicine|April 3, 2016
HIV Pharmacist's Impact on Inpatient Antiretroviral ErrorsM D Liedtke, C R Tomlin, G H Skrepnek, et al.
Pageof 2